Tag: Pharma

Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery

Elix, Inc. and the Graduate School of Life Sciences at Tohoku University  are pleased to announce the signing…

CM Plus launches “pharmo.AI” for pharma research support

CM Plus Co., Ltd. has officially released "pharmo.AI," an AI search system that supports regulatory intelligence (RI) and…

Nxera Pharma to Get $10M from AbbVie for Neuro Project

Nxera Pharma Co., Ltd. has announced the achievement of a significant second R&D milestone under its multi-target discovery…

FerroptoCure Inc Concludes Series A Round

Tokyo biotech startup FerroptoCure has raised ¥460 million in Series A funding. This money will help speed up…

CRISPR and Beyond: Japan’s Strategic Blueprint for the Future of Gene Editing

Gene editing is no longer a lab experiment sitting in the background. For Japan, it has become a…

FUJIFILM and argenx Extend Collaboration to U.S. Operations

FUJIFILM Biotechnologies, a top global CDMO for biologics and vaccines, is expanding its partnership with argenx SE, an…

Interview with Shinya Yuki, CEO and co-founder of Elix.

CEO and co-founder of Elix. Born in Yamagata, Japan. During graduate school, engaged in research on astrophysics through…

Rohto Pharma Builds Global Platform with Dynamics 365

Hitachi Solutions, Ltd. has implemented Microsoft Dynamics 365 at Rohto Pharmaceutical Co., Ltd., a global company engaged in…

Hitachi and KSK Team Up on Pharma Delivery Digitalization

KSK Corporation and Hitachi, Ltd. have begun a collaborative creation project to utilize advanced digital technologies to digitally…

Eisai seeks FDA approval for LEQEMBI Subcutaneous dose

Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics License Application (sBLA) with the U.S.…

MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two companies have signed an exclusive global…

Eisai’s Tazemetostat Approved as Orphan Drug in Japan

Eisai Co., Ltd. announced that it has received orphan drug designation for anticancer agent the EZH2 inhibitor tazemetostat…

Join Our Community

Join Our Community